DDAVP Stimulates Prostacyclin Production

Summary

Des-amino-D-arginine vasopressin (DDAVP) stimulates the release of factor VIII and plasminogen activator from the vascular endothelium. An infusion of exogenous factor VIII given to haemophiliacs causes an increase in platelet activation. This activation does not occur after stimulating a rise in the patient's own factor VIII level caused by DDAVP infusion. We hypothesised therefore that DDAVP could also cause the endothelial release of prostacyclin (PGI₂), a potent anti-platelet agent which would counteract the aggregating effect of factor VIII. To examine this possibility we studied the effect of DDAVP on prostacyclin release, as measured by its stable metabolite 6-oxo-PGFla, in vitro and in vivo. Rabbit aortic rings were incubated with different concentrations of DDAVP using saline as control. The supernatant was assayed for 6-oxo-PGFlct by radioimmunoassay. All concentrations of DDAVP gave a significant release of 6-oxo-PGF_1α. Vasopressin was much less potent. When DDAVP was infused into haemophilic patients there was a significant increase in circulating 6-oxo-PGF_1α levels immediately after the infusion. The facial flushing observed as a side-effect of DDAVP could therefore be prostacyclin-mediated. We confirmed this by abolishing the DDAVP induced flushing seen in normal subjects by prior treatment with aspirin which inhibits PGI₂ formation.

Key words

DDAVP - Prostacyclin - Platelet aggregation - Factor VIII

• References

• 1 Cash JD, Gader AMA, Da Costa J. Release of plasminogen activator and Factor VIII in response to LVP, AVP, DDAVP, angiotensin II and oxytocin in man. Br J Haematol 1974; 27: 363-364
• 2 Grigani G, Ortis M, Gamba G, Ascari E. “In-vitro” effect of factor VIII concentrates on human normal platelets. Haematologica 1978; 63: 132-136
• 3 Grigani G, Gamba G, Ascari E. “In-vivo” platelet aggregates after replacement therapy in patients with Haemophilia A. Thromb Haemostas 1979; 42: 813-814
• 4 Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; II: 924-927
• 5 Belch JJF, Douglas JT, Lowe GDO, Forbes CD, Prentice CRM. Platelet aggregation after elevation of Factor VIII following DDAVP infusion in Haemophilia A patients. Thromb Haemostas 1980; 44: 168
• 6 O’Grady J, Warrington S, Moti MJ. Effects of intravenous infusion of prostacyclin (PGI₂) in man. Prostaglandins 1980; 19 (02) 319-332
• 7 Mitchel MD. A sensitive radioimmunoassay for 6 keto prostaglandin. Prostaglandins and Medicine 1978; 1: 13-21
• 8 Granstrom E, Kindall H. Radioimmunoassay of prostaglandins and thromboxanes. In: Frolich JC. Advances in Prostaglandin and thromboxane research. New York: Raven Press; 1978: 119-209
• 9 Mannucci PM, Aberg M, Wilsson IM, Robertson B. Mechanism of plasminogen activator and Factor VIII increase after vasoactive drugs. Br J Haematol 1975; 30: 81-93